UBS Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.32M | Buy |
|
|||||
|
2025
Q2 | $1.53M | Sell |
|
|||||
|
2025
Q1 | $2.59M | Sell |
|
|||||
|
2024
Q4 | $5.71M | Buy |
|
|||||
|
2024
Q3 | $4.9M | Sell |
|
|||||
|
2024
Q2 | $4.91M | Buy |
|
|||||
|
2024
Q1 | $3.53M | Buy |
|
|||||
|
2023
Q4 | $4.4M | Buy |
|
|||||
|
2023
Q3 | $845K | Buy |
|
|||||
|
2023
Q2 | $853K | Sell |
|
|||||
|
2023
Q1 | $862K | Buy |
|
|||||
|
2022
Q4 | $478K | Buy |
|
|||||
|
2022
Q3 | $434K | Sell |
|
|||||
|
2022
Q2 | $958K | Sell |
|
|||||
|
2022
Q1 | $1M | Buy |
|
|||||
|
2021
Q4 | $313K | Buy |
|
|||||
|
2021
Q3 | $176K | Sell |
|
|||||
|
2021
Q2 | $623K | Sell |
|
|||||
|
2021
Q1 | $769K | Sell |
|
|||||
|
2020
Q4 | $865K | Buy |
|
|||||
|
2020
Q3 | $320K | Sell |
|
|||||
|
2020
Q2 | $798K | Buy |
|
|||||
|
2020
Q1 | $458K | Sell |
|
|||||
|
2019
Q4 | $1.26M | Buy |
|
|||||
|
2019
Q3 | $1.26M | Buy |
|
|||||
|
2019
Q2 | $1.11M | Buy |
|
|||||
|
2019
Q1 | $873K | Buy |
|
|||||
|
2018
Q4 | $278K | Sell |
|
|||||
|
2018
Q3 | $289K | Buy |
|
|||||
|
2018
Q2 | $49K | Sell |
|
|||||
|
2018
Q1 | $131K | Buy |
|
|||||
|
2017
Q4 | $127K | Buy |
|
|||||
|
2017
Q3 | $82K | Sell |
|
|||||
|
2017
Q2 | $134K | Sell |
|
|||||
|
2017
Q1 | $136K | Sell |
|
|||||
|
2016
Q4 | $174K | Sell |
|
|||||
|
2016
Q3 | $260K | Buy |
|
|||||
|
2016
Q2 | $111K | Sell |
|
|||||
|
2016
Q1 | $234K | Sell |
|
|||||
|
2015
Q4 | $292K | Buy |
|
|||||
|
2015
Q3 | $25K | Buy |
|
|||||
|
2015
Q2 | $9K | Sell |
|
|||||
|
2015
Q1 | $64K | Buy |
|
|||||
|
2014
Q4 | $3K | Buy |
|